These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6733561)

  • 21. Radiotherapy dose-fractionation schedules. Hyperfractionation and accelerated treatment regimens.
    Freeman CR; Lehnert S
    Neurol Clin; 1991 May; 9(2):351-62. PubMed ID: 1944104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calculation of the biological effect of fractionated radiotherapy: the importance of radiation-induced apoptosis.
    Olsen DR
    Br J Radiol; 1995 Nov; 68(815):1230-6. PubMed ID: 8542231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Optimal fractionation from the radiobiological viewpoint].
    Kummermehr J
    Radiobiol Radiother (Berl); 1989; 30(3):181-92. PubMed ID: 2672076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Derivation of the optimum dose per fraction from the linear quadratic model.
    Jones B; Tan LT; Dale RG
    Br J Radiol; 1995 Aug; 68(812):894-902. PubMed ID: 7551788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.
    Fu KK; Clery M; Ang KK; Byhardt RW; Maor MH; Beitler JJ
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):589-97. PubMed ID: 7790243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flexure dose: the low-dose limit of effective fractionation.
    Tucker SL; Thames HD
    Int J Radiat Oncol Biol Phys; 1983 Sep; 9(9):1373-83. PubMed ID: 6885550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003.
    Fu KK; Pajak TF; Trotti A; Jones CU; Spencer SA; Phillips TL; Garden AS; Ridge JA; Cooper JS; Ang KK
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):7-16. PubMed ID: 10924966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mathematical simulation of radiation therapy of solid tumors. II. Fractionation.
    Fischer JJ
    Acta Radiol Ther Phys Biol; 1971 Apr; 10(2):267-78. PubMed ID: 5556825
    [No Abstract]   [Full Text] [Related]  

  • 29. [Dose-time optimization in fractionated radiotherapy].
    Kriester A; Kloetzer KH; Kob D
    Strahlenther Onkol; 1988 Aug; 164(8):489-98. PubMed ID: 3138769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accelerated Hypofractionated Radiotherapy Versus Stereotactic Body Radiotherapy for the Treatment of Stage I Nonsmall Cell Lung Cancer-A Single Institution Experience With Long-Term Follow-Up.
    Karasawa K; Hayakawa S; Machitori Y; Shibata Y; Ogawa H; Ito K; Shimizuguchi T; Kawamoto T; Nihei K
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818806318. PubMed ID: 30317929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is there a radiobiologic basis for improving the treatment of advanced stage cervical cancer?
    Lindegaard JC; Overgaard J; Bentzen SM; Pedersen D
    J Natl Cancer Inst Monogr; 1996; (21):105-12. PubMed ID: 9023838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutron radiobiology revisited.
    Denekamp J
    Acta Oncol; 1994; 33(3):233-40. PubMed ID: 8018351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered and conventional fractionated radiotherapy in locoregional control and survival of patients with squamous cell carcinoma of the larynx, oropharynx, and hypopharynx.
    Krstevska V; Crvenkova S
    Croat Med J; 2006 Feb; 47(1):42-52. PubMed ID: 16489696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of accelerated radiotherapy for patients with inoperable non-small cell lung cancer (NSCLC) and borderline prognostic factors without distant metastasis: a retrospective review.
    Nguyen LN; Komaki R; Allen P; Schea RA; Milas L
    Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1053-6. PubMed ID: 10421538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical implications of incomplete repair parameters for rat spinal cord: the feasibility of large doses per fraction in PDR and HDR brachytherapy.
    Pop LA; Millar WT; Visser AG; van der Kogel AJ
    Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):215-26. PubMed ID: 11516872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantification of tumor reoxygenation during accelerated radiation therapy.
    Kocher M; Treuer H; Müller RP
    Radiology; 1997 Oct; 205(1):263-8. PubMed ID: 9314996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extending the linear-quadratic model for large fraction doses pertinent to stereotactic radiotherapy.
    Guerrero M; Li XA
    Phys Med Biol; 2004 Oct; 49(20):4825-35. PubMed ID: 15566178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Dose-response relationship in radiotherapy: an evidence?].
    Chauvet B; de Rauglaudre G; Mineur L; Alfonsi M; Reboul F
    Cancer Radiother; 2003 Nov; 7 Suppl 1():8s-14s. PubMed ID: 15124539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The predictability of the radiotherapy response in epidermoid tumors of the head and neck. A review of the literature and mathematical models for choosing the fractionated doses].
    Corvò R; Scarpati D; Sanguineti G; Vitale V
    Radiol Med; 1990 May; 79(5):520-9. PubMed ID: 2193325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered fractionation schedules in radiation treatment: a review.
    Ahmed KA; Correa CR; Dilling TJ; Rao NG; Shridhar R; Trotti AM; Wilder RB; Caudell JJ
    Semin Oncol; 2014 Dec; 41(6):730-50. PubMed ID: 25499633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.